Form 4: Biohaven Director John W. Childs Receives Additional Shares Due to Merger Calculation Error
SEC Form 4 Filing
Director John W. Childs receives additional Biohaven shares to correct a calculation error related to a previous merger transaction.
Summary
- John W. Childs, a director at Biohaven Ltd., received an additional 2,091 common shares on April 5, 2024, due to a calculation error related to a merger transaction consummated on January 8, 2024.
- The original merger involved the exchange of 48,505 common shares of Biohaven for shares of common stock of the acquired company held by Childs.
- The transaction was approved by the Board of the Issuer pursuant to Rule 16b-3.
- Following this transaction, Childs directly owns 2,181,671 shares indirectly through the John W Childs 2013 Revocable Trust.
Sentiment
Score: 7
Explanation: The document is neutral in sentiment as it reports a correction of a previous transaction. It doesn't indicate positive or negative performance, but rather ensures accuracy in reporting.
Industry Context
This announcement reflects standard regulatory reporting for corporate insiders and highlights the importance of accurate share calculation in merger transactions. It is typical for companies to correct errors and disclose them promptly to maintain transparency with shareholders and regulatory bodies.
Stakeholder Impact
- The correction of the share calculation ensures accurate representation of ownership, which is important for shareholders.
Key Dates
| Date | Description |
|---|---|
| January 8, 2024 | Date of the merger transaction. |
| April 5, 2024 | Date John W. Childs received additional shares to correct the calculation error. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.